Edgewise Therapeutics's total assets for Q1 2025 were $454.39M, a decrease of -6.66% from the previous quarter. EWTX total liabilities were $24.67M for the fiscal quarter, a -10.61% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.